1. Home
  2. DENN vs ENGN Comparison

DENN vs ENGN Comparison

Compare DENN & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denny's Corporation

DENN

Denny's Corporation

HOLD

Current Price

$6.21

Market Cap

319.8M

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.85

Market Cap

379.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DENN
ENGN
Founded
1953
1999
Country
United States
Canada
Employees
N/A
N/A
Industry
Restaurants
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
319.8M
379.3M
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
DENN
ENGN
Price
$6.21
$8.85
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$5.45
$22.71
AVG Volume (30 Days)
1.9M
314.7K
Earning Date
11-03-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$457,212,000.00
N/A
Revenue This Year
$6.56
N/A
Revenue Next Year
$1.56
N/A
P/E Ratio
$31.66
N/A
Revenue Growth
0.93
N/A
52 Week Low
$2.85
$2.65
52 Week High
$7.66
$11.14

Technical Indicators

Market Signals
Indicator
DENN
ENGN
Relative Strength Index (RSI) 65.73 58.82
Support Level $6.13 $7.57
Resistance Level $6.24 $8.47
Average True Range (ATR) 0.02 0.63
MACD -0.03 0.03
Stochastic Oscillator 50.00 80.25

Price Performance

Historical Comparison
DENN
ENGN

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: